Eiken Chemical Co., Ltd.
4549.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$80.3B
Close$
Share Statistics
| Market cap | $80.30 Billion |
|---|---|
| Enterprise Value | $76.29 Billion |
| Dividend Yield | $58.00 (2.38%) |
| Earnings per Share | $112.5 |
| Beta | 0.74 |
| Outstanding Shares | 32,965,573 |
Return
| Return on Equity | 8.17% |
|---|---|
| Return on Assets | 5.74% |
| Return on Invested Capital | 9.98% |
Valuation & Multiples
| P/E Ratio | 22.59 |
|---|---|
| PEG | -87.46 |
| Price to Sales | 1.89 |
| Price to Book Ratio | 1.85 |
| Enterprise Value to Revenue | 1.8 |
| Enterprise Value to EBIT | 16.12 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$10.20 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$10.88 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Eiken Chemical Co., Ltd.
696 employees
CEO: Yuji Segawa Eiken Chemical Co., Ltd. is a Japanese manufacturer and distributor specializing in clinical diagnostic products and medical equipment. The company excels in developing diagnostic solutions for diverse medical fields, encompassing bioche...